Evidence map›Paper›PMID 33147796›Full record

ReviewJournal of clinical medicine2020

Methylene Blue-Current Knowledge, Fluorescent Properties, and Its Future Use.

Tomasz Cwalinski, Wojciech Polom, Luigi Marano, Giandomenico Roviello, Alberto D'Angelo, Natalia Cwalina, Marcin Matuszewski, Franco Roviello, Janusz Jaskiewicz, Karol Polom

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 145 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. A comprehensive method for quantifying human cytomegalovirus plaque assays.Frontiers in cellular and infection microbiology · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 4 countries.

Tomasz CwalinskiDepartment of Surgical Oncology, Medical University of Gdansk, 80-214 Gdansk, Poland.ORCID 0000-0002-1506-9735
Wojciech PolomDepartment of Urology, Medical University of Gdansk, 80-214 Gdansk, Poland.
Luigi MaranoDepartment of Medicine, Surgery and Neurosciences, Unit of General Surgery and Surgical Oncology, University of Siena, 53-100 Siena, Italy.ORCID 0000-0002-9777-9588
Giandomenico RovielloDepartment of Health Sciences, University of Florence, viale Pieraccini 6, 50139 Florence, Italy.
Alberto D'AngeloDepartment of Biology and Biochemistry, University of Bath, Bath BA2 7AY, UK.
Natalia CwalinaDepartment of Pediatrics Ascension St. John Children's Hospital, Detroit, MI 48236, USA.
Marcin MatuszewskiDepartment of Urology, Medical University of Gdansk, 80-214 Gdansk, Poland.
Franco RovielloDepartment of Medicine, Surgery and Neurosciences, Unit of General Surgery and Surgical Oncology, University of Siena, 53-100 Siena, Italy.
Janusz JaskiewiczDepartment of Surgical Oncology, Medical University of Gdansk, 80-214 Gdansk, Poland.
Karol PolomDepartment of Surgical Oncology, Medical University of Gdansk, 80-214 Gdansk, Poland.
Gdańsk Medical University · PLUniversity of Siena · ITChildren's Hospital of Michigan · USUniversity of Bath · GBUniversity of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methylene blue is a fluorescent dye discovered in 1876 and has since been used in different scientific fields. Only recently has methylene blue been used for intraoperative fluorescent imaging. Here, the authors review the emerging role of methylene blue, not only as a dye used in clinical practice, but also as a fluorophore in a surgical setting. We discuss the promising potential of methylene blue together with the challenges and limitations among specific surgical techniques. A literature review of PubMed and Medline was conducted based on the historical, current and future usage of methylene blue within the field of medicine. We reviewed not only the current usage of methylene blue, but we also tried to grasp its' function as a fluorophore in five main domains. These domains include the near-infrared imaging visualization of ureters, parathyroid gland identification, pancreatic tumors imaging, detection of breast cancer tumor margins, as well as breast cancer sentinel node biopsy. Methylene blue is used in countless clinical procedures with a relatively low risk for patients. Usage of its fluorescent properties is still at an early stage and more pre-clinical, as well as clinical research, must be performed to fully understand its potentials and limitations.

Indexed as

fluorescencefluorophoremethylene blue

Identifiers

PMID33147796
PMCPMC7693951
OpenAlexW3095803259

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.